Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Express 2007
Issue number 672: July 02, 2007
 
Contents of this Issue
Select a title to jump to the article.
  1. New: CDC publishes ACIP's influenza vaccination recommendations for 2007
  2. ACIP votes to recommend routine use of meningococcal conjugate vaccine in adolescents ages 11-18 years
  3. Reformatted: IAC's popular online Ask the Experts web section offers users fast, easy navigation
  4. IAC introduces new pieces that answer patients' questions about Hib and shingles (zoster)
  5. September 15 is the date for CHOP's Vaccine Education Symposium
  6. New: CDLHN offers CD of printable materials to promote the use of Tdap vaccine to professionals and adult patients
  7. Annual Immunize Georgia Conference set for September 20 in College Park, GA
 
Abbreviations
AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; AMA, American Medical Association; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD, National Center for Immunization and Respiratory Diseases; NIVS, National Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization.
  
Issue 672: July 2, 2007
1.  New: CDC publishes ACIP's influenza vaccination recommendations for 2007

CDC published "Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007" in electronic format in the June 29 MMWR Early Release. The summary and a box titled "Persons for Whom Annual Vaccination Is Recommended" are reprinted below.


SUMMARY
This report updates the 2006 recommendations by CDC's Advisory Committee on Immunization Practices (ACIP) regarding the use of influenza vaccine and antiviral agents (CDC. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices [ACIP]. MMWR 2006;55[No. RR-10]). The groups of persons for whom vaccination is recommended and the antiviral medications recommended for chemoprophylaxis or treatment (oseltamivir or zanamivir) have not changed. Estimated vaccination coverage remains <50% among certain groups for whom routine annual vaccination is recommended, including young children and adults with risk factors for influenza complications, healthcare personnel (HCP), and pregnant women. Strategies to improve vaccination coverage, including use of reminder/recall systems and standing orders programs, should be implemented or expanded. The 2007 recommendations include new and updated information.

Principal updates and changes include
(1) reemphasizing the importance of administering 2 doses of vaccine to all children aged 6 months-8 years if they have not been vaccinated previously at any time with either live, attenuated influenza vaccine (doses separated by =>6 weeks) or trivalent inactivated influenza vaccine (doses separated by =>4 weeks), with single annual doses in subsequent years;

(2) recommending that children aged 6 months-8 years who received only 1 dose in their first year of vaccination receive 2 doses the following year, with single annual doses in subsequent years;

(3) highlighting a previous recommendation that all persons, including school-aged children, who want to reduce the risk of becoming ill with influenza or of transmitting influenza to others should be vaccinated;

(4) emphasizing that immunization providers should offer influenza vaccine and schedule immunization clinics throughout the influenza season;

(5) recommending that healthcare facilities consider the level of vaccination coverage among HCP to be one measure of a patient-safety quality program and implement policies to encourage HCP vaccination (e.g., obtaining signed statements from HCP who decline influenza vaccination); and

(6) using the 2007-2008 trivalent vaccine virus strains A/Solomon Islands/3/2006 (H1N1)-like (new for this season), A/Wisconsin/67/2005 (H3N2)-like, and B/Malaysia/2506/2004-like antigens.

This report and other information are available at CDC's influenza website (http://www.cdc.gov/flu). Updates or supplements to these recommendations (e.g., expanded age or risk-group indications for currently licensed vaccines) might be required. Immunization providers should be alert to announcements of recommendation updates and should check the CDC influenza website periodically for additional information. . . .

BOX. PERSONS FOR WHOM ANNUAL VACCINATION IS RECOMMENDED
Annual vaccination against influenza is recommended for
  • all persons, including school-aged children, who want to reduce the risk of becoming ill with influenza or of transmitting influenza to others;
     
  • all children aged 6-59 months (i.e., 6 months-4 years);
     
  • all persons aged >=50 years;
     
  • children and adolescents (aged 6 months-18 years) receiving long-term aspirin therapy who therefore might be at risk for experiencing Reye syndrome after influenza virus infection;
     
  • women who will be pregnant during the influenza season;
     
  • adults and children who have chronic pulmonary (including asthma), cardiovascular (except hypertension), renal, hepatic, hematological or metabolic disorders (including diabetes mellitus);
     
  • adults and children who have immunosuppression (including immunosuppression caused by medications or by human immunodeficiency virus);
     
  • adults and children who have any condition (e.g., cognitive dysfunction, spinal cord injuries, seizure disorders, or other neuromuscular disorders) that can compromise respiratory function or the handling of respiratory secretions or that can increase the risk for aspiration;
     
  • residents of nursing homes and other chronic-care facilities;
     
  • healthcare personnel;
     
  • healthy household contacts (including children) and caregivers of children aged <5 years and adults aged >=50 years, with particular emphasis on vaccinating contacts of children aged <6 months; and
     
  • healthy household contacts (including children) and caregivers of persons with medical conditions that put them at higher risk for severe complications from influenza. . . .

To access a ready-to-print (PDF) version of the recommendations, go to: http://www.cdc.gov/mmwr/pdf/rr/rr56e629.pdf

To access a web-text (HTML) version of the recommendations, go to: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr56e629a1.htm

To receive a FREE electronic subscription to MMWR (which includes new ACIP statements), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html

Back to top
   
2 ACIP votes to recommend routine use of meningococcal conjugate vaccine in adolescents ages 11-18 years

At its June 27-28 meeting, ACIP voted to expand part of its recommendations for the use of meningococcal conjugate vaccine (MCV4). ACIP voted to recommend giving a one-time dose of MCV4 to all adolescents ages 11-18 years. The vote does not alter the remainder of the recommendations, which includes giving the vaccine to college freshmen living in dormitories and to other persons at risk for meningococcal disease or its complications.

ACIP recommendations become the official recommendations of CDC once they are accepted by the director of CDC and the Secretary of Health and Human Services and are published in the Morbidity and Mortality Weekly Report.

Back to top
   
3 Reformatted: IAC's popular online Ask the Experts web section offers users fast, easy navigation

IAC recently reformatted its very popular and much-visited online Ask the Experts web section. Ask the Experts is a compilation of questions and answers about immunization and viral hepatitis that have appeared in past issues of IAC's three print periodicals, Needle Tips, Vaccinate Adults, and Vaccinate Women. It is written by CDC experts William L. Atkinson, MD, MPH; Andrew T. Kroger, MD, MPH; and Joanna Buffington, MD, MPH.

The section's main page now features a clean, visually appealing design, a disease/vaccine index, and a left-column navigation bar. In addition, many of the disease/vaccine pages offer users an index of subtopics pertinent to the disease/vaccine, as well as tables and other graphic elements that organize and explain complex information.

Information in the Ask the Experts web section is reviewed at least every six months and updated as necessary. Please browse through it at your convenience, and visit it whenever you need reliable, comprehensive immunization and hepatitis information. To access it, go to: http://www.immunize.org/askexperts

Back to top
   
4 IAC introduces new pieces that answer patients' questions about Hib and shingles (zoster)

IAC recently developed ready-to-print versions of some of the CDC-reviewed Q&A material located on IAC's Vaccine Information website (www.vaccineinformation.org). The website is intended for the public, health professionals, and the media.

The newly formatted Q&As present information on the following diseases and vaccines: Hib and shingles (zoster). In the next several weeks, IAC Express will announce the availability of more ready-to-print Q&As on additional vaccine-preventable diseases and vaccines.

Organized in an easy-to-follow Q&A format, these pieces can be printed and handed out to patients to help educate them about the seriousness of VPDs and the importance of vaccination. Links to the new ready-to-print Q&As follow:

To access "Hib: Questions and Answers," go to:
http://www.immunize.org/catg.d/p4206.pdf

To access "Shingles (Zoster): Questions and Answers," go to:
http://www.immunize.org/catg.d/p4221.pdf

In the June 4, 11, 18, and 25 issues of IAC Express, we announced newly formatted Q&As on 14 other diseases and vaccines. Following are the direct links to them:

To access "Chickenpox (Varicella): Questions and Answers," go to: http://www.immunize.org/catg.d/p4202.pdf

To access "Diphtheria: Questions and Answers," go to:
http://www.immunize.org/catg.d/p4203.pdf

To access "HPV: Questions and Answers," go to:
http://www.immunize.org/catg.d/p4207.pdf

To access "Tetanus: Questions and Answers," go to:
http://www.immunize.org/catg.d/p4220.pdf

To access "Rubella: Questions and Answers," go to:
http://www.immunize.org/catg.d/p4218.pdf

To access "Polio: Questions and Answers," go to:
http://www.immunize.org/catg.d/p4215.pdf

To access "Meningococcal: Questions and Answers," go to:
http://www.immunize.org/catg.d/p4210.pdf

To access "Rotavirus: Questions and Answers," go to:
http://www.immunize.org/catg.d/p4217.pdf

To access "Mumps: Questions and Answers," go to:
http://www.immunize.org/catg.d/p4211.pdf

To access "Pertussis: Questions and Answers," go to:
http://www.immunize.org/catg.d/p4212.pdf

To access "PPV: Questions and Answers," go to:
http://www.immunize.org/catg.d/p4213.pdf

To access "Hepatitis A: Questions and Answers," go to:
http://www.immunize.org/catg.d/p4204.pdf

To access "Hepatitis B: Questions and Answers," go to:
http://www.immunize.org/catg.d/p4205.pdf

To access "Measles: Questions and Answers," go to:
http://www.immunize.org/catg.d/p4209.pdf

To access IAC's online disease/vaccine Q&A material for patients and parents, go to: http://www.vaccineinformation.org and click on the pertinent link(s).

Back to top
   
5 September 15 is the date for CHOP's Vaccine Education Symposium

On September 15, the Vaccine Education Center at Children's Hospital of Philadelphia (CHOP) is sponsoring a one-day symposium for health professionals that will focus on concerns and questions related to vaccine financing, science, and exemptions. The following topics will be discussed:

  • History of vaccines
  • Medical update of thimerosal in vaccines
  • Thimerosal in court
  • Thimerosal in the Vaccine Injury Compensation Program
  • Influenza vaccination of healthcare personnel
  • Philosophical exemptions and pertussis
  • Rights of those who choose vaccination

To access a ready-to-print (PDF) version of the symposium brochure, go to:
http://www.chop.edu/cme/2007/vaccine/pdf/vaccine_std.pdf

For additional information, contact CHOP's Continuing Medical Education Department at (215) 590-5263 or visit http://www.chop.edu/cme

Back to top
   
6 New: CDLHN offers CD of printable materials to promote the use of Tdap vaccine to professionals and adult patients

The California Distance Learning Health Network (CDLHN) is now offering a CD of six printable flyers that promote the use of Tdap vaccine to health professionals, parents, and adult patients. The files on the CD can be edited to include an organization's contact information, logo, or other information.

The flyers on the CD include the following:

  • "Grandparents: Protect Your Grandbabies from Whooping Cough"
  • "Parents: Protect Yourself and Your Children from Whooping Cough"
  • "Protect Your Baby from Whooping Cough"
  • "If You Work in a Health Care Setting: It's Time for Your Tetanus Booster"
  • "Check Your Vials: Is it Tdap, DTaP, or Td?"
  • "Tetanus Prophylaxis in Wound Management"

The CD costs $25. To order, go to: http://cdlhn.com and click "Online Store" in the navigation column at the left of the page.

Back to top
   
7 Annual Immunize Georgia Conference set for September 20 in College Park, GA

The annual Immunize Georgia Conference will be held on September 20 at the Georgia International Convention Center, College Park, GA (near the Atlanta International Airport). The registration deadline is August 28; late registrations will be accepted after that date. The conference is sponsored by the Georgia Department of Human Resources and Children's Healthcare of Atlanta.

To access a comprehensive conference brochure, which includes registration, program, and speaker information, go to: http://www.choa.org/menus/documents/cme/ImmGA.pdf

For additional information, contact Angie Matthiessen at (404) 785-7225 or angie.matthiessen@choa.org

Back to top
   
Immunization Action Coalition  •  1573 Selby Ave  •  St. Paul, MN 55104
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.